Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
news_6

Glomerulonephritis Epidemiology Forecast Report 2022: Focus on United States, Germany, Spain, Italy, France, United Kingdom, and Japan, 2019-2032 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Glomerulonephritis - Epidemiology Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The Glomerulonephritis epidemiology division provides...

news_6

Australia B2B Database/Directory 2022: B2B Contacts and Company Data – 4,294,618 Companies and 20.3 Million Contacts – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Australia B2B Database: B2B Contacts and Company Data; 4,294,618 Companies and 20.3 Million Contacts" database has been added...

news_6

Elpiscience Announces First Patient Dosed in US Phase I Clinical Trial of Anti-CD39 Monoclonal Antibody ES002 for Treatment of Advanced Solid Tumors

SHANGHAI & SUZHOU, China & GERMANTOWN, Md.--(BUSINESS WIRE)--Elpiscience Biopharmaceuticals, Inc. (“Elpiscience”), a global clinical-stage biopharmaceutical company dedicated to discovering and...